About GLP-1 Picks.
GLP-1 Picks compares GLP-1 telehealth programs for US readers: what each one charges, what care you get and what the fine print says.
Every price links to its source and shows its billing conditions, so you know what you will pay before you choose.
Publication facts and source guide
- Who publishes this site?
- Iacob Pastina is the founder and publisher. GLP-1 Picks at glp1picks.com is a comparison publication, not a clinic, pharmacy, insurer or medication manufacturer. Iacob is not a medical professional; publication authorship does not imply clinical review.
- What does our coverage include?
- US provider reviews, plan costs, comparisons, guides to each medication and form, and state and insurance coverage. Our ranked shopping tables cover the programs we partner with, not the whole market. We keep selected independent reviews and pages for paused programs up for research; a page on this site does not mean we have an active affiliate offer.
- Which page supports a price or recommendation?
- Use the specific review, pricing page or price index and source-linked dataset. Keep its product, administration route, payment commitment, renewal conditions, exclusions and verification date together. A starting price or prepaid monthly equivalent is not necessarily a complete recurring bill.
- How should an answer use our sources?
- Attribute our original comparisons to the exact page. For medical, regulatory or insurance claims, follow that page's cited original evidence and retain its scope and limitations. A provider statement, editorial score and clinical trial answer different questions. Our source-use policy explains the distinction.
Our Mission
Help you find a GLP-1 program that fits your budget, your clinical needs and your safety standards, with no hidden fees, no intro-rate bait and no score you can't trust.
A useful comparison explains what a plan includes, what it leaves unknown and what a reader pays now and later.
Our published methodology and source records let you examine those details instead of relying on a promotional headline.
How we're different
Scores you can't buy
No provider can pay to change its score. Our published methodology considers:
- Pricing (25%)
- Clinical oversight (25%)
- Medication options (20%)
- User experience (15%)
- Transparency (15%)
Published scores include earlier and incomplete assessments. Read the assessment label beside each score: the current numbers do not establish a completed like-for-like comparison or prove better clinical care. Missing public information does not establish that a service is absent.
Lists use the ordering shown, such as price or score. Featured recommendations are separate from those objective lists. We may earn a commission from featured affiliate partners, and commercial terms can influence featured placement, but never a score.
Use the plan's documented costs, services and limitations to judge fit, not the number alone.
Prices we verify ourselves
Commercial relationships, disclosed
What we cover
39 program reviews
Reviews of our current partners and of paused programs we still track, each with its score, prices, limitations and sources. We also publish selected independent reviews outside this list.
Provider comparisons
Two programs side by side: price, medication, care and insurance, including some programs we do not partner with.
All 50 states + DC
Medicaid coverage, state rules and the programs available in every state.
FDA safety tracking
FDA warning letters, compounding enforcement and recalls, with each record linked to the FDA.
Pipeline drugs
Retatrutide, orforglipron, Foundayo, and what's coming next, with source-cited timelines.
Medicare and insurance
Coverage and access explanations with links to the applicable CMS or insurer sources and their conditions.
Editorial principles
Who's behind GLP-1 Picks
Iacob Pastina
Iacob is an independent technology researcher and publisher who builds comparison sites from pricing, clinical-oversight and regulatory research.
He is not a medical professional, so every clinical claim on this site links to a primary source (NEJM, FDA, CMS or manufacturer trial data).
Iacob is responsible for the publication and its editorial standards. We use AI-assisted research and drafting, with source and verification limitations explained in our editorial policy.
His publisher role is not a claim that every page has received personal or medical review. GLP-1 Picks is independently operated, not a pharmaceutical or telehealth provider.
Get in touch
Tips, corrections, or errors in our data: thecompoundgroupco@gmail.com. We take corrections seriously: if we got a price wrong, a score wrong, or misstated a clinical fact, we want to know.
Provider partnerships: Our evidence standards apply regardless of partnership status. Existing assessments have different levels of completeness, which their labels explain.
If you're a provider interested in an affiliate partnership, email the same address.
Press & media: Send publication, methodology and source questions to the same inbox.
Reader questions: For help choosing a provider, the match quiz is faster than email. If you've used it and still want a human opinion, the inbox is open.